Nymox Pharmaceutical Gross Margin Growth & History (NYMXF)

Nymox Pharmaceutical's gross margin was 20.00% for fiscal 2020.

View full Nymox Pharmaceutical company overview

Nymox Pharmaceutical annual gross margin history

Nymox Pharmaceutical annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20202020-12-3120.00%−30.00 pp
20192019-12-3150.00%−3.85 pp
20182018-12-3153.85%+20.36 pp
20172017-12-3133.48%−5.60 pp
20162016-12-3139.08%−55.12 pp
20152015-12-3194.20%

Nymox Pharmaceutical gross margin trends

Over the last five fiscal years, Nymox Pharmaceutical's gross margin decreased from 94.20% to 20.00%, a change of −74.20 percentage points. The latest reported quarter, Q1 2020, shows 20.00%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nymox Pharmaceutical source filings ↗

Community posts

It’s quiet here.

No posts about NYMXF yet. Start the conversation.

Write the first post